Office

Auditor/Sponsor Document Repository

ODQ Policy Documents

  • ADM-100: Creation and Maintenance of HCC Policies and Operations

  • ADM-OP-1: Maintenance and Use of the HCC Listserv

  • ADM-OP-2: Maintenance of the AAHRPP Accreditation

  • AUD-100: Audits and Inspections

  • AUD-OP-1: Internal Auditing Procedures

  • AUD-OP-2: FDA and Other Regulatory Inspections

  • COM-100: Human Research Oversight and Operations Committees

  • COM-OP-1: Maintenance of the OncPro Priority List

  • COM-OP-2: Accrual Monitoring Procedures and Scientific Progress Review by the SRC

  • COM-OP-5: DSMC Procedures, Review and Data Compliance

  • COM-OP-6: DSMB Procedures and Review

  • CON-100: Informed Consent Process

  • CON-101: Obtaining Consent of Non-English Speakers

  • DATA-100: Data Management of Investigator-Sponsored Therapeutic Protocols

  • DATA-101: Case Report Form (CRF) Development

  • DATA-OP-1: Data Requests

  • DATA-OP-2: Obtaining Missing Forms Reports

  • DATA-OP-9: Data Set Finalization and InForm eCRF Retirement

  • DOC-100: Subject Research Charts

  • EDU-100: Training Requirements for Research Personnel

  • INV-100: Research Pharmacy Standard Policy

  • INV-101: Transfer of Investigational Drug

  • INV-103: Protocol Mandated Drug Taken at Home

  • INV-OP-1: Mandatory Research Pharmacy Standard Procedures

  • MON-101: Research Conduct Oversight by External Sponsors

  • MULTI-100: Conducting HCC Investigator-Sponsored Multi-Center Trials

  • MULTI-OP-1: Review and Approval Process for Investigator-Sponsored Multi-Center Trials

  • REGIST-100: Eligibility Checklists

  • REGIST-101: Subject Registration

  • REGIST-OP-1: Subject Registration Procedures

  • REGIST-OP-3: Eligibility Checklist Development

  • REGIST-OP-4: NCI Clinical Trials Reporting Program (CTRP) Compliance

  • REGIST-200: Registration on ClinicalTrials.gov

  • RCO-100: Investigator-Sponsored Research

  • RCO-102: Responsibilities of Investigators

  • RCO-103: Confidentiality and Secondary Use of Research Information

  • RCO-104: New Protocol Submission Requirements

  • RCO-203: Regulatory Documentation

  • RCO-204: Safety and Event Reporting

  • RCO-OP-1: Documenting Delegation of Authority

  • RCO-OP-2: Completion of Form FDA 1572

  • RCO-OP-3: Performance of Protocol Specified Procedures at Non-HCC Sites

  • RCO-OP-4: Obtaining and Maintaining an IND

  • RCO-OP-5: Obtaining and Maintaining an IDE

  • RCL-100: Preparation for Site Close Out

  • RCL-101: Record Retention for Completed Research

  • RCL-OP-1: Study Completion Procedures

OHRS Policy Documents

  • HIPAA Info Sheet Research

  • IRB Policies and Procedures for the Protection of Human Subjects 1

  • IRB Policies and Procedures for the Protection of Human Subjects

  • IS Guidance Sharing and Transfer of Data or Specimens

  • IS Guidance Updating Consent forms Approved Prior to 2019

  • IS Policy Administrative Closures

  • IS Policy Adverse Event and INDSR Reporting Policy Effective 03 17 2025

  • IS Policy Blood Draws from Healthy Volunteers

  • IS Policy Consenting Blind and Illiterate Participants

  • IS Policy Continued Participation

  • IS Policy Determining if Project Is Human Subjects

  • IS Policy Deviation Violation Exception Reporting

  • IS Policy DFCI IRB Requirements Relating to the Honest Broker in Biobanking

  • IS Policy Implementing Dose Escalation

  • IS Policy Institutional Conflicts of Interest

  • IS Policy Legally Authorized Representatives

  • IS Policy Linked and Anonymous

  • IS Policy Non English Speaking Subjects

  • IS Policy Outside Interest Disclosure

  • IS Policy Pregnant Partner Consent and Data Collection

  • IS Policy Prisoners in Research

  • IS Policy Sharing Protocols

  • IS Policy Short Form Translation Procedure

  • IS Policy Single Patient IND and Emergency Use of a Test Article

  • IS Policy Subject Injury Language

  • IS Policy Two Year CR

  • IS Policy Use of Alert Pages

  • IS Sponsor Requests for PHI Related to Adverse or Severe Adverse Events

  • Letter to Sponsors

OHRS Guidance Info Sheets

  • CLC Consortium Guidance Final

  • Guidance Adobe Sign for Electronic Consent

  • Guidance DFCI Clinical Trials Adobe Sign FA Qs

  • IS Guidance Audio Recording in Human Subjects Research

  • IS Guidance Case Reports

  • IS Guidance CLIA Requirements

  • IS Guidance DFCI IRB Approved Standard Drug Risk Language

  • IS Guidance Drug Shortages

  • IS Guidance Electronic Consent

  • IS Guidance Guidance for Study Teams and Sponsors Information Regarding Approvable and Not Approvable Langua

  • IS Guidance HCC Specimens and Data External Sites Checklist

  • IS Guidance Institutional Certification for Genomic Data Sharing

  • IS Guidance Institutional Engagement

  • IS Guidance IRB Review of Data Safety Monitoring Plans

  • IS Guidance MA State Law Involving Human Research

  • IS Guidance Medical Devices

  • IS Guidance Procedures for Monitoring the Consent Process

  • IS Guidance Reconsent and New Risk Notification

  • IS Guidance Research Funded or Supported by the Department of Defense

  • IS Guidance Research Limited to the Use of Data or Specimens

  • IS Guidance Research Procedures at External Sites

  • IS Guidance Return of Individual Results

  • IS Guidance Scientific Progress Review

  • IS Guidance Statistical Guidelines for Non Clinical Research

  • IS Guidance The Use of Social Media in Recruitment to Research

  • IS Guidance Withdrawal of Consent to Continue in Research Form

  • IS Guidance European Union General Data Protection Regulation GDPR

  • IS Guidance Relying on an External SRC

OHRS Resource Info Sheets

  • Guidance Adobe Sign Consent Message Language

  • IS Resource Additional Protections for Children

  • IS Resource Criteria for IRB approval of research

  • IS Resource Expedited and Exempt Categories

  • IS Resource Massachusetts Law on Insurance Coverage

  • IS Resource Partners Recruitment of Subjects

  • IS Resource Required Elements of Consent

  • IS Resource Requirements for Informed Consent

  • IS Resource Successful Research Participation Communication

  • Research Participant Adobe Sign Instructions

OHRS Operations Info Sheets

  • IS Operations Continuing Review and the 2018 Common Rule jce

  • IS Operations Guidance Priority List

  • IS Operations Onc Pro Guide

  • IS Operations Overview DFCI IR Bs

  • IS Operations Use of Informed Consent Documents Posted to Onc Pro

OHRS Worksheets and Checklists

  • HRP 306 WORKSHEET Drugs

  • HRP 307 WORKSHEET Devices

  • HRP 310 WORKSHEET Human Research Determination

  • HRP 311 WORKSHEET Engagement Determination

  • HRP 312 WORKSHEET Exemption

  • HRP 313 WORKSHEET Expedited Review

  • HRP 314 WORKSHEET Criteria for Approval

  • HRP 317 WORKSHEET Short Form of Consent Documentation

  • HRP 321 WORKSHEET Reportable New Information

  • HRP 322 WORKSHEET Emergency Use

  • HRP 323 WORKSHEET Criteria for Approval HUD

  • HRP 325 WORKSHEET Device Compassionate Use

  • HRP 330 WORKSHEET HIPAA Authorization

  • HRP 332 WORKSHEET NIH GDS Institutional Certfication

  • HRP 410 CHECKLIST Waiver or Alteration of Consent Process

  • HRP 412 CHECKLIST Pregnant Women

  • HRP 411 CHECKLIST Waiver of Written Documentation of Consent

  • HRP 415 CHECKLIST Prisoners

  • HRP 416 CHECKLIST Children

  • HRP 417 CHECKLIST Cognitively Impaired Adults

  • HRP 419 CHECKLIST Waiver of Consent Process for Emergency Research

  • HRP 430 CHECKLIST Investigator Quality Improvement Assessment

  • HRP 441 CHECKLIST HIPAA Waiver of Authorization